Advertisement
Screener

PAVmed Inc. (PAVM) Revenue from Contract with Customer, Excluding Assessed Tax

1.8 / 5 stars · 20/56 Roast Me

PAVmed Inc. Revenue from Contract with Customer, Excluding Assessed Tax

PAVmed Inc. (PAVM) reported Revenue from Contract with Customer, Excluding Assessed Tax of $33.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Revenue

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-13

  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $33.00K, a 450.00% increase year-over-year.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $22.00K, a 175.00% increase year-over-year.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $52.00K, a 420.00% increase year-over-year.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $5.00K, a 99.50% decline year-over-year.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $71.00K, a 97.63% decline from fiscal 2024.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $3.00M, a 22.15% increase from fiscal 2023.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $2.45M, a 550.40% increase from fiscal 2022.
  • PAVmed Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $377.00K, a 24.60% decline from fiscal 2021.
Period endRevenue from Contract with Customer, Excluding Assessed Tax 3 monthRevenue from Contract with Customer, Excluding Assessed Tax 6 monthRevenue from Contract with Customer, Excluding Assessed Tax 9 monthRevenue from Contract with Customer, Excluding Assessed Tax 12 month
2026-06-30$33.00K
10-Q · filed 2026-08-13
$55.00K
10-Q · filed 2026-08-13
$107.00K
derived: sum of 3 quarters · filed 2026-08-13
$112.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$22.00K
10-Q · filed 2026-05-14
$74.00K
derived: sum of 2 quarters · filed 2026-05-14
$79.00K
derived: sum of 3 quarters · filed 2026-05-14
$85.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$52.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$57.00K
derived: sum of 2 quarters · filed 2026-03-27
$63.00K
derived: sum of 3 quarters · filed 2026-08-13
$71.00K
10-K · filed 2026-03-27
2025-09-30$5.00K
10-Q · filed 2025-11-12
$11.00K
derived: sum of 2 quarters · filed 2026-08-13
$19.00K
10-Q · filed 2025-11-12
$29.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$6.00K
10-Q · filed 2026-08-13
$14.00K
10-Q · filed 2026-08-13
$24.00K
derived: sum of 3 quarters · filed 2026-08-13
$1.02M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$8.00K
10-Q · filed 2026-05-14
$18.00K
derived: sum of 2 quarters · filed 2026-05-14
$1.01M
derived: sum of 3 quarters · filed 2026-05-14
$1.99M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$1.01M
derived: sum of 2 quarters · filed 2026-03-27
$1.99M
derived: sum of 3 quarters · filed 2026-03-27
$3.00M
10-K · filed 2026-03-27
2024-09-30$996.00K
10-Q · filed 2025-11-12
$1.98M
derived: sum of 2 quarters · filed 2025-11-12
$2.98M
10-Q · filed 2025-11-12
$4.03M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$979.00K
10-Q · filed 2025-08-14
$1.99M
10-Q · filed 2025-08-14
$3.04M
derived: sum of 3 quarters · filed 2025-08-14
$3.83M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.01M
10-Q · filed 2025-05-15
$2.06M
derived: sum of 2 quarters · filed 2025-05-15
$2.85M
derived: sum of 3 quarters · filed 2025-05-15
$3.02M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$1.84M
derived: sum of 2 quarters · filed 2025-03-24
$2.01M
derived: sum of 3 quarters · filed 2025-03-24
$2.45M
10-K · filed 2025-03-24
2023-09-30$791.00K
10-Q · filed 2024-11-14
$957.00K
derived: sum of 2 quarters · filed 2024-11-14
$1.40M
10-Q · filed 2024-11-14
$1.51M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$166.00K
10-Q · filed 2024-08-12
$612.00K
10-Q · filed 2024-08-12
$724.00K
derived: sum of 3 quarters · filed 2024-08-12
$800.00K
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$446.00K
10-Q · filed 2024-05-13
$558.00K
derived: sum of 2 quarters · filed 2024-05-13
$634.00K
derived: sum of 3 quarters · filed 2024-05-13
$634.00K
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$112.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
$188.00K
derived: sum of 2 quarters · filed 2024-03-25
$188.00K
derived: sum of 3 quarters · filed 2024-03-25
$377.00K
10-K · filed 2024-03-25
2022-09-30$76.00K
10-Q · filed 2023-11-13
$76.00K
derived: sum of 2 quarters · filed 2023-11-13
$265.00K
10-Q · filed 2023-11-13
$565.00K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$189.00K
10-Q · filed 2023-08-14
$489.00K
derived: sum of 3 quarters · filed 2023-08-14
$689.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$189.00K
10-Q · filed 2023-05-15
$489.00K
derived: sum of 2 quarters · filed 2023-05-15
$689.00K
derived: sum of 3 quarters · filed 2023-05-15
2021-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
$500.00K
derived: sum of 2 quarters · filed 2023-03-14
$500.00K
10-K · filed 2023-03-14
2021-09-30$200.00K
10-Q · filed 2022-11-14
$200.00K
10-Q · filed 2022-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14